In vivo studies in wild type mice demonstrate SERPINA1 mRNA biodistribution in liver and lungs, as well as SerpinA1 protein expression in these two target organs which are critically affected in AAT deficiency. The gene discussed is SERPINA1; the disease is alpha 1-antitrypsin deficiency.